Patents by Inventor Axel Wollenschläger

Axel Wollenschläger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180036249
    Abstract: The present invention pertains to a pharmaceutical composition comprising the compound of the formula (I) in a high concentration and at least one pharmaceutically acceptable excipient, the use of the composition for the treatment of hyper-proliforative diseases, such as cancer, either as a sole agent, or in combination with other anti-cancer therapies, and the process for preparing of said composition.
    Type: Application
    Filed: August 22, 2017
    Publication date: February 8, 2018
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Fritz SCHUCKLER, Axel Wollenschlaeger
  • Patent number: 9737488
    Abstract: The present invention pertains to a pharmaceutical composition comprising the compound of the formula (I) in a high concentration and at least one pharmaceutically acceptable excipient, the use of the composition for the treatment of hyper-proliferative diseases, such as cancer, either as a sole agent, or in combination with other anti-cancer therapies, and the process for preparing of said composition.
    Type: Grant
    Filed: February 22, 2006
    Date of Patent: August 22, 2017
    Assignee: Bayer HealthCare LLC
    Inventors: Fritz Schückler, Axel Wollenschläger